Ticker Details
Bioventus Inc.
IPO Date:	February 11, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$574.66M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 3.07%
Avg Daily Range (30 D):	$0.15 | 1.87%
Avg Daily Range (90 D):	$0.16 | 2.07%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.19M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	42
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	196
Avg Institutional Trade:	$1.4M
Avg Institutional Trade (30 D):	$.62M
Avg Institutional Trade (90 D):	$.69M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.64M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.67M
Avg Closing Volume:	187.01K

News

Aug 4, 2025 @ 12:00 PM Bioventus Enters into a New $400 Million Senior Se... Source: Dave Crawford

Apr 10, 2025 @ 5:30 AM Intramedullary Nail Market size to worth USD 1,537... Source: Coherent Market Insights

Nov 26, 2024 @ 4:00 PM Osteoarthritis Therapeutics Market Size to Reach U... Source: Precedence Research

Oct 4, 2024 @ 9:52 AM U.S. Osteoarthritis Injectables Market Analysis 20... Source: Researchandmarkets.Com

Sep 24, 2024 @ 4:23 PM First September Gains in 5 Years? Buy 3 Breakout S... Source: Zacks

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$.16	$.05	$.11
Diluted EPS	$.16	$.05	$.11
Revenue	$563.83M	$138.65M	$147.66M
Gross Profit	$382.03M	$94.23M	$102.09M
Net Income / Loss	$12.57M	$4.01M	$9.27M
Operating Income / Loss	$45.41M	$11.25M	$18.37M
Cost of Revenue	$181.8M	$44.42M	$45.57M
Net Cash Flow	$-.91M	$9.25M	$10.11M
PE Ratio	54.50